Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
出版年份 2017 全文链接
标题
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
作者
关键词
-
出版物
NUCLEIC ACIDS RESEARCH
Volume 45, Issue 13, Pages 7897-7908
出版商
Oxford University Press (OUP)
发表日期
2017-05-25
DOI
10.1093/nar/gkx490
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Cas-analyzer: an online tool for assessing genome editing results using NGS data
- (2016) Jeongbin Park et al. BIOINFORMATICS
- Therapeutic applications of CRISPR RNA-guided genome editing
- (2016) Taeyoung Koo et al. Briefings in Functional Genomics
- Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
- (2016) Tang Liu et al. CANCER LETTERS
- SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line
- (2016) Wen Feng et al. GENE
- Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model
- (2016) A-Rum Yoon et al. JOURNAL OF CONTROLLED RELEASE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Allele-specific locus binding and genome editing by CRISPR at the p16INK4a locus
- (2016) Toshitsugu Fujita et al. Scientific Reports
- Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
- (2015) Cory Smith et al. MOLECULAR THERAPY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
- (2015) Simona Valletta et al. Oncotarget
- EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
- (2015) Meng-Feng Tsai et al. Scientific Reports
- An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
- (2015) Brandon J. Aubrey et al. Cell Reports
- 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
- (2014) B. Besse et al. ANNALS OF ONCOLOGY
- Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
- (2014) Qiurong Ding et al. CIRCULATION RESEARCH
- Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9
- (2014) Ranran Cheng et al. FEBS LETTERS
- Targeting Cdk11 in osteosarcoma cells using the CRISPR-cas9 system
- (2014) Yong Feng et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975/gefinitib-resistant with epidermal growth factor receptor T790M mutation
- (2014) BAO-XIA ZHAO et al. Molecular Medicine Reports
- A guide to genome engineering with programmable nucleases
- (2014) Hyongbum Kim et al. NATURE REVIEWS GENETICS
- Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
- (2014) Yuchen Liu et al. Nature Communications
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
- (2013) Brenda K. Edwards et al. CANCER
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
- (2013) Haoyi Wang et al. CELL
- Heritable Gene Knockout in Caenorhabditis elegans by Direct Injection of Cas9–sgRNA Ribonucleoproteins
- (2013) Seung Woo Cho et al. GENETICS
- Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases
- (2013) Y. H. Sung et al. GENOME RESEARCH
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
- (2013) Seung Woo Cho et al. NATURE BIOTECHNOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer
- (2012) Nicola K Green et al. Nanomedicine
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- The use of oncolytic viruses to overcome lung cancer drug resistance
- (2012) Vladimir Beljanski et al. Current Opinion in Virology
- Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease
- (2009) Tomoya Fukui et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer gene therapy with targeted adenoviruses
- (2008) Houria Bachtarzi et al. Expert Opinion on Drug Delivery
- Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
- (2008) J Y Yoo et al. GENE THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search